Structural insights into the design of indole derivatives as tubulin polymerization inhibitors

FEBS Lett. 2020 Jan;594(1):199-204. doi: 10.1002/1873-3468.13566. Epub 2019 Aug 16.

Abstract

Microtubules are composed of αβ-tubulin heterodimers, and drugs that interfere with microtubule dynamics are used widely in cancer chemotherapy. Small synthetic molecules with an indole nucleus as a core structure have been identified as microtubule inhibitors and recognized as anticancer agents. However, structural information for the interactions between indole derivatives and tubulin is sparse. Here, we present the 2.55 Å crystal structure of tubulin in complex with the indole derivative D64131. We compare the binding modes of D64131, colchicine, and five other indole derivatives to tubulin. These results reveal the interactions between the indole derivatives and tubulin, explain previous results of structure-activity-relationship (SAR) studies and, thus, provide insights into the development of new indole derivatives targeting the colchicine binding site.

Keywords: D64131; colchicine binding site; drug design; indole; tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Colchicine / chemistry
  • Colchicine / pharmacology
  • Indoles / chemistry*
  • Indoles / pharmacology
  • Molecular Docking Simulation*
  • Protein Binding
  • Protein Multimerization
  • Quantitative Structure-Activity Relationship
  • Tubulin / chemistry*
  • Tubulin / metabolism
  • Tubulin Modulators / chemistry*
  • Tubulin Modulators / pharmacology

Substances

  • Indoles
  • Tubulin
  • Tubulin Modulators
  • Colchicine